6 news items
Century Therapeutics Presents Preclinical Data Highlighting Advances in iPSC Platform Technology and Programs at 2024 ASGCT Annual Meeting
IPSC
10 May 24
clinical trials as well as third-party suppliers and manufacturers; our ability to successfully commercialize our product candidates and develop sales
Century Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
IPSC
9 May 24
suppliers and manufacturers; our ability to successfully commercialize our product candidates and develop sales and marketing capabilities, if our product
Century Therapeutics Strengthens Position in Autoimmune Disease with Strategic Pipeline Expansion Supported by $60 Million Private Placement and Acquisition of Clade Therapeutics
IPSC
11 Apr 24
-party suppliers and manufacturers; our ability to successfully commercialize our product candidates and develop sales and marketing capabilities
Century Therapeutics Presents New Preclinical Data Highlighting iPSC-derived Cell Therapy Platform Technology at the 2024 American Association for Cancer Research (AACR) Annual Meeting
IPSC
8 Apr 24
product candidates, including third parties conducting our clinical trials as well as third-party suppliers and manufacturers; our ability
Century Therapeutics Reports Full Year 2023 Financial Results and Provides Business Updates
IPSC
14 Mar 24
conducting our clinical trials as well as third-party suppliers and manufacturers; our ability to successfully commercialize our product candidates
xc4colj63hmega729cpgbxbum6322s5x3bystrdaze4 8jveq7n58fr0cavq
IPSC
5 Mar 24
of our product candidates, including third parties conducting our clinical trials as well as third-party suppliers and manufacturers; our ability
- Prev
- 1
- Next